Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TOVORAFENIB vs TRANDOLAPRIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TOVORAFENIB vs TRANDOLAPRIL: Safety Overview

Metric TOVORAFENIB TRANDOLAPRIL
Total FAERS Reports 201 617
Deaths Reported 6 48
Death Rate 3.0% 7.8%
Hospitalizations 18 318
Average Patient Age 19.6 yrs 65.0 yrs
% Female Patients 62.5% 46.0%
FDA Approval Date Apr 23, 2024 Apr 26, 1996
Manufacturer Day One Biopharmaceuticals, Inc. Epic Pharma, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued